BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 19155730)

  • 1. CD4+, CD56+ mycosis fungoides: case report and review of the literature.
    Horst BA; Kasper R; LeBoit PE
    Am J Dermatopathol; 2009 Feb; 31(1):74-6. PubMed ID: 19155730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycosis fungoides with a CD56+ immunophenotype.
    Wain EM; Orchard GE; Mayou S; Atherton DJ; Misch KJ; Russell-Jones R
    J Am Acad Dermatol; 2005 Jul; 53(1):158-63. PubMed ID: 15965442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poikilodermatous mycosis fungoides with a CD8+ CD56+ immunophenotype: a case report and literature review.
    Shiomi T; Monobe Y; Kuwabara C; Hayashi H; Yamamoto T; Sadahira Y
    J Cutan Pathol; 2013 Mar; 40(3):317-20. PubMed ID: 23241021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
    Izban KF; Hsi ED; Alkan S
    Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
    Moore PF; Olivry T; Naydan D
    Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-positive CD4/CD8 mycosis fungoides: a rarely reported immunohistochemical profile.
    Tournier E; Laurent C; Thomas M; Meyer N; Viraben R; Brousset P; Lamant L
    J Cutan Pathol; 2014 Jan; 41(1):58-62. PubMed ID: 24134789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A; Dhungel BM; Khan MF
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
    Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
    Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant.
    Knapp CF; Mathew R; Messina JL; Lien MH
    Am J Dermatopathol; 2012 May; 34(3):e37-9. PubMed ID: 22356917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
    Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
    Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood mycosis fungoides with a CD8+ CD56+ cytotoxic immunophenotype.
    Poppe H; Kerstan A; Böckers M; Goebeler M; Geissinger E; Rosenwald A; Hamm H
    J Cutan Pathol; 2015 Apr; 42(4):258-64. PubMed ID: 25442255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8-positive granulomatous mycosis fungoides: a case report with review of the literature.
    Ishida M; Hotta M; Takikita-Suzuki M; Kojima F; Okabe H
    J Cutan Pathol; 2010 Oct; 37(10):1072-6. PubMed ID: 20579213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD20+ mycosis fungoides: a report of three cases and review of the literature.
    Hagen JW; Schaefer JT; Magro CM
    Am J Dermatopathol; 2013 Dec; 35(8):833-41. PubMed ID: 24247573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
    Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
    Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient with clinicopathologic features of small plaque parapsoriasis presenting later with plaque-stage mycosis fungoides: report of a case and comparative retrospective study of 27 cases of "nonprogressive" small plaque parapsoriasis.
    Belousova IE; Vanecek T; Samtsov AV; Michal M; Kazakov DV
    J Am Acad Dermatol; 2008 Sep; 59(3):474-82. PubMed ID: 18694680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
    Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological spectrum of mycosis fungoides type cutaneous T-cell lymphoma.
    Shaikh ZI; Rahman SB
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):171-4. PubMed ID: 16542594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.